|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/12 | |
| A61K 9/72 | |||
| A61K 47/02 | |||
| A61K 31/573 | |||
| A61K 31/58 | |||
| A61K 31/4704 |
| (11) | Patento numeris | 1850831 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 06706899.9 |
| Europos patento paraiškos padavimo data | 2006-02-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-11-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-12-02 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2006/001287 |
| Data | 2006-02-13 |
| (87) | Numeris | WO 2006/089656 |
| Data | 2006-08-31 |
| (30) | Numeris | Data | Šalis |
| 05004233 | 2005-02-25 | EP |
| (72) |
LEWIS, David Andrew, IT
MEAKIN, Brian John, IT
DELCANALE, Maurizio, IT
PIVETTI, Fausto, IT
|
| (73) |
CHIESI FARMACEUTICI S.p.A.,
Via Palermo 26/A, 43100 Parma,
IT
|
| (54) | PHARMACEUTICAL AEROSOL FORMULATIONS FOR PRESSURIZED METERED DOSE INHALERS COMPRISING A SEQUESTERING AGENT |
| PHARMACEUTICAL AEROSOL FORMULATIONS FOR PRESSURIZED METERED DOSE INHALERS COMPRISING A SEQUESTERING AGENT |